Financial statements Financial statements of the group: Operating assets and liabilities DIAGEO ANNUAL REPORT 2017 127 of the group up to a value of 200 million 175 million.
Following the actuarial triennial valuation as of 31 December 2015, the group made additional cash contributions of 32 million 28 million during the year ended 30 June 2017, and has agreed to pay a further 9 million 8 million in each of the next two years.
The group has also agreed to make conditional payments up to a maximum of 29 million 25 million if the deficit on the plan is greater than 232 million 204 million at the 2018 actuarial triennial valuation.
The conditional payments would be made equally over the three years after the 2018 actuarial triennial valuation has been agreed.
e Timing of benefit payments The following table provides information on the timing of the benefit payments and the average duration of the defined benefit obligations and the distribution of the timing of benefit payments: United Kingdom Ireland United States 2017 2016 2017 2016 2017 2016 million million million million million million Maturity analysis of benefits expected to be paid Within one year 347 272 76 74 57 61 Between 1 to 5 years 1,079 998 374 359 243 175 Between 6 to 15 years 2,800 2,724 742 702 366 387 Between 16 to 25 years 2,511 2,530 701 662 234 266 Beyond 25 years 4,201 4,210 1,170 1,121 198 253 Total 10,938 10,734 3,063 2,918 1,098 1,142 years years years years years years Average duration of the defined benefit obligation 19 18 19 20 10 11 The projected benefit payments are based on the assumptions underlying the assessment of the obligations, including inflation.
They are disclosed undiscounted and therefore appear large relative to the discounted value of the plan liabilities recognised in the consolidated balance sheet.
They are in respect of benefits that have accrued at the balance sheet date and make no allowance for any benefits accrued subsequently.
f Related party disclosures Information on transactions between the group and its pension plans is given in note 20.
Working capital a Inventories 2017 2016 Accounting policies million million Inventories are stated at the lower of cost and net realisable value.
Raw materials and consumables 327 301 Cost includes raw materials, direct labour and expenses, an Work in progress 45 49 appropriate proportion of production and other overheads, but Maturing inventories 3,820 3,647 not borrowing costs.
Cost is calculated at the weighted average Finished goods and goods for resale 596 582 cost incurred in acquiring inventories.
Maturing inventories which 4,788 4,579 are retained for more than one year are classified as current assets, as they are expected to be realised in the normal operating cycle.
Trade and other receivables are initially recognised at fair value Maturing inventories include whisk e y, rum, tequila and Chinese less transaction costs and subsequently carried at amortised costs white spirits.
The following amounts of inventories are expected less any allowance for discounts and doubtful debts.
to be utilised after more than one year: Trade and other payables are initially recognised at fair value 2017 2016 including transaction costs and subsequently carried at million million amortised costs.
Raw materials and consumables 8 27 Provisions are liabilities of uncertain timing or amount.
Maturing inventories 3,194 3,180 A provision is recognised if, as a result of a past event, the group 3,202 3,207 has a present legal or constructive obligation that can be estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation.
Provisions are Inventories are disclosed net of provisions for obsolescence, an calculated on a discounted basis.
The carrying amounts of analysis of which is as follows: provisions are reviewed at each balance sheet date and adjusted 2017 2016 to reflect the current best estimate.
million million Balance at beginning of the year 73 53 Exchange differences 1 5 Income statement charge 41 33 Utilised 25 15 Sale of businesses 3 88 73 128 DIAGEO ANNUAL REPORT 2017 Financial statements of the group: Operating assets and liabilities b Trade and other receivables c Trade and other payables i 2017 2016 2017 2016 Current Non-current Current Non-current Current Non-current Current Non-current assets assets assets assets liabilities liabilities liabilities liabilities million million million million million million million million Trade receivables 2,130 2,154 1 Trade payables 1,365 1,088 Interest receivable 19 20 Interest payable 75 81 Other receivables 244 45 281 36 Tax and social security Prepayments 159 13 189 9 excluding Accrued income 40 42 income tax 543 2 605 3 2,592 58 2,686 46 Other payables 487 16 508 37 Accruals 1,064 6 1,056 9 Deferred income 29 34 21 At 30 June 2017, approximately 15%, 21% and 12% of the groups trade receivables of 2,130 million are due from counterparties based in the 3,563 24 3,372 70 United Kingdom, the United States and India, respectively.
i T he group has revised the disclosure of trade payables and other payables as at 30 June 2016 to The aged analysis of trade receivables, net of allowances, is as be consistent with the current year presentation.
follows: 2017 2016 Interest payable at 30 June 2017 includes interest on non-derivative million million financial instruments of 68 million 2016 73 million.
Not overdue 2,026 2,012 d Provisions Overdue 1 30 days 28 60 Overdue 31 60 days 19 25 Thalidomide Other Total million million million Overdue 61 90 days 11 16 At 30 June 2016 190 200 390 Overdue 91 180 days 21 21 Exchange differences 1 5 6 Overdue more than 180 days 25 21 Provisions charged during 2,130 2,155 the year 64 95 159 Provisions utilised during the year 40 106 146 Trade and other receivables are disclosed net of allowance for Transfers 2 2 doubtful debts, an analysis of which is as follows: Unwinding of discounts 8 8 2017 2016 At 30 June 2017 223 192 415 million million Current liabilities 18 111 129 Balance at beginning of the year 83 71 Non-current liabilities 205 81 286 Exchange differences 1 5 223 192 415 Income statement charge 54 15 Written off 7 8 a Provisions have been established in respect of the discounted 129 83 value of the groups commitment to the UK and Australian Thalidomide Trusts.
These will be utilised over the period of the The income statement charge includes 32 million in respect of commitments up to 2037.
See note 8. a claim made by a customer in India.
See note 4 b. b The largest items in other provisions at 30 June 2017 are 48 million in respect of employee deferred compensation plans which will be utilised when employees leave the group and 33 million in respect of the Turkish Competition Authority investigation into Mey kis trading practices in Turkey.
